Investor mix
13 investors on record; lead investors include RA Capital Management; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 38% |
| Angel & family office | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 6 | 46% |
Provider of RNA-based therapeutics for multiple health purposes
13 investors on record; lead investors include RA Capital Management; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 38% |
| Angel & family office | 1 | 8% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 6 | 46% |